Global CRO footprint Leverage Julius Clinical's expanded global integration with Peachtree BioResearch Solutions to pitch a fully integrated CNS and cardio-metabolic trial capability across North America and Europe, appealing to sponsors seeking streamlined global execution and site access.

Therapeutic leadership Highlight the company’s strength in CNS, neurology, cardiovascular and metabolic programs, backed by academically recognized leaders and a global investigator network to attract sponsors aiming for high-quality, specialized trial execution.

Recent mergers Capitalize on the merged entity’s broader service offerings and integrated operations post May 2025 to present a single, scalable CRO solution with enhanced capabilities in neuroscience, vaccines, and infectious diseases to prospective clients seeking breadth and depth.

Digital and data readiness Promote the tech stack including Sage Intacct, Power BI, SAS, and collaborative platforms to position the company as data-driven and capable of integrated analytics, project controls, and real-time trial intelligence for sponsor transparency.

Financial health signals With a revenue range of 25–50 million and a mid-sized team, present a compelling value proposition of cost-effective, high-quality trial execution with flexible engagement models suitable for mid-market biotechs and emerging pharma seeking efficient CRO partnerships.